Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 401–450 of 505 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05112614	Role of Gut Microbiome in Cancer Therapy	recruiting	—	3,000	Mayo ClinicOTHER	1	Mar 16, 2026	clinicaltrials
NCT07475182	Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers	recruiting	Early Phase 1	10	Hainan Cancer HospitalOTHER	1	Mar 16, 2026	clinicaltrials
NCT05364086